Premier Inc

Latest Results (02.03.2026):

Premier Inc. reported results for its fiscal-year 2025 fourth quarter (ended June 30, 2025). Total net revenue was $262.9 million (down 12% year-over-year, up 1% sequentially). GAAP net income from continuing operations was $18.0 million, or $0.22 per diluted share. Adjusted EBITDA was $68.9 million and adjusted EPS was $0.43 for the quarter (adjusted EPS excluding Contigo Health was $0.46). The company generated $417.8 million of operating cash flow for the full year and free cash flow of $180.5 million.

Top-line and quarter comparison

Total net revenue (continuing operations) for the fiscal‑2025 fourth quarter was $262.9M, down 12% versus Q4 FY2024 but up 1% versus Q3 FY2025. Net revenue excluding Contigo Health was $257.97M for the quarter (also down ~12% YoY).

Profitability

GAAP net income from continuing operations fell to $18.0M (Q4 FY2024: $60.9M), driving diluted GAAP EPS of $0.22 (vs. $0.57 prior year). Adjusted EBITDA was $68.9M (down 34% YoY) and adjusted EPS was $0.43 (down 30% YoY); excluding Contigo Health the adjusted EPS was $0.46.

Segment performance

Supply Chain Services: net revenue $170.0M (‑8% YoY) and segment adjusted EBITDA $90.0M (‑18% YoY). Performance Services: net revenue $92.9M (‑20% YoY) and segment adjusted EBITDA $17.2M (‑48% YoY). Supply Chain strength (including growth in software/licenses and co‑management) offset some consulting and license timing weakness in Performance Services.

Cash flow and balance sheet

Full‑year net cash provided by operating activities from continuing operations was $417.8M; free cash flow was $180.5M. Cash and cash equivalents at June 30, 2025 were $83.7M and the company had $280M outstanding on its $1.0B revolving credit facility.

Return of capital

Under its 2024 repurchase authorization (expired June 30, 2025) Premier repurchased $800M of common stock, including completion of a $200M accelerated share repurchase in August 2025. The company paid $77.4M in dividends during FY2025 and the Board declared a $0.21 quarterly cash dividend on August 17, 2025.

Contigo Health and portfolio actions

Premier continues to wind down or transition remaining Contigo Health operations and presents certain non‑GAAP measures excluding Contigo (the company expects Contigo to be substantially transitioned or wound down by Dec 31, 2025). The S2S Global direct sourcing business was divested on Oct 1, 2024; results shown are for continuing operations.

Guidance for fiscal‑2026

Fiscal‑2026 guidance (excluding Contigo Health) targets total net revenue of $940M–$1.0B, Supply Chain Services $590M–$620M, Performance Services (ex‑Contigo) $350M–$380M, adjusted EBITDA $230M–$245M, and adjusted EPS $1.33–$1.43 (diluted shares 81M–83M). Guidance assumes Contigo contributions will be minimal or eliminated.

One‑time and non‑GAAP drivers

Quarterly GAAP results were affected by higher stock‑based compensation, asset impairments and other items noted by management. The company emphasizes its non‑GAAP measures (adjusted EBITDA, adjusted EPS, free cash flow) and provides reconciliations in the release.